Browsing Tag
Orion Corporation
5 posts
FDA accepts Bayer’s application to expand NUBEQA’s use in prostate cancer treatment
The U.S. Food and Drug Administration (FDA) has accepted Bayer’s supplemental new drug application (sNDA) for NUBEQA (darolutamide),…
November 23, 2024
Merck secures exclusive global license for opevesostat from Orion Corporation
Merck (NYSE: MRK), also known as MSD outside the United States and Canada, has enhanced its strategic position…
July 7, 2024
Ami Organics bolsters collaboration with Fermion, signs agreement for new pharma intermediates
Ami Organics Limited, a global leader in manufacturing advanced pharmaceutical intermediates and specialty chemicals, has signed a definitive…
December 16, 2023
Ami Organics wins multi-million Euro supply contract from Fermion
Ami Organics has signed a multi-year, multi-tonne agreement with Fermion, a wholly-owned subsidiary of Finland-based Orion Corporation for…
November 27, 2022
Merck signs $290m deal with Orion Corporation for mCRPC candidate ODM-208
Merck has signed a global development and commercialization deal worth $290 million with Orion Corporation for the latter’s…
July 16, 2022